EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
25/11/2025
Voltar para busca
Dado oficial do USPTO
KANGPU
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
27/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42
Data de depósito
02/11/2016
Data de registro
19/06/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/06/2018
Última transação
27/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Shanghai, CN
Examinador
MALYSZEK,KIMBERLY RAY
Localização atual
Historical data usage
Titulares e representantes
Titulares
KANGPU BIOPHARMACEUTICALS LTD.
Representantes
Charles Ho Barron & Young PLLC
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for human purposesmedicines for the treatment of cancerautoimmune disease and inflammation-related disease; biochemical drugdrugs for the treatment of cancerautoimmune disease and inflammation-related disease; medicinal drinks; biological preparations for medical purposesmedical preparations for the treatment of cancerautoimmune disease and inflammation- related disease; pharmaceutical preparationspharmaceutical preparations for the treatment of cancerautoimmune disease and inflammation-related disease; Drug delivery agents in the form of powderstablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; traditional Chinese medicinesmedicinal herbal preparations; diagnostic preparations for medical purposes; drugs for medical purposesdosage form such as tabletscapsulespills for the treatment of cancerautoimmune disease and inflammation-related diseases; dietetic foods adapted for medical use
Classe 35
Demonstration of goods; advertising services; business management assistance; organizing exhibitions for commercial or advertising purposes in the field of technological goods and services; provision of an on-line marketplace for buyers and sellers of goods and services; import- export agency services; retail and wholesale store services featuring pharmaceuticalveterinarysanitary preparations and medical supplies; retail and wholesale store services featuring pharmaceuticals; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring medical supplies
Classe 42
Research and development of new products for others; technical research in the field of pharmaceutical studies and development; quality control for others; product quality testing for others; chemical research; chemistry consultation services; bacteriological research; biological research; conducting clinical trials for others; material testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
PR71
POST REGISTRATION ACTION MAILED - SEC.71
24/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/12/2024
ES71
TEAS SECTION 71 RECEIVED
06/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/04/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
19/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/10/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/09/2018
FIMP
FINAL DISPOSITION PROCESSED
22/09/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/09/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
19/06/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2018
PUBO
PUBLISHED FOR OPPOSITION
03/04/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/02/2018
ATRV
ATTORNEY REVIEW COMPLETED
26/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/02/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/02/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/02/2018
RFNT
REFUSAL PROCESSED BY IB
09/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
25/08/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/08/2017
RFRR
REFUSAL PROCESSED BY MPU
23/08/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/08/2017
CNRT
NON-FINAL ACTION WRITTEN
21/08/2017
DOCK
ASSIGNED TO EXAMINER
21/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/08/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KANGPU ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.